IMDX as of Nov 1 · 22:46 ET
IMDXNasdaqIn Vitro & In Vivo Diagnostic Substances

Insight Molecular Diagnostics Inc. · Brief

Next report

7 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±70.8%▼−7.13%×0.10
quarterimplied−75%0+75%realized×
Q2 FY26±70.8%▼−7.13%×0.10
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

40managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+4.31%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

2managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
7 of 19of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IMDX report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.